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Objective: The aim of this article is to report our experience in the surgical treatment of arterial aneurysms in patients with
Behçet disease.
Methods: From October 2001 through May 2004, 18 arterial aneurysms were diagnosed in 16 Behçet patients. All patients
were male. The patients ranged in age from 24 to 52 years (mean, 37.4  5.2 years). There were six abdominal aortic,
three common femoral, two iliac, two popliteal, two superficial femoral, and two anterior tibial aneurysms and one
subclavian artery aneurysm. All patients but four were in remission at the time of diagnosis. Those 4 patients received
immunosuppressive therapy before the surgical intervention to induce remission. After hospital discharge, all patients
were followed up regularly at 3-month intervals. The mean duration of follow-up was 17  4.2 months (range, 6-24
months).
Results: All patients underwent a successful surgical intervention. During the study period, we performed five aortic tube
graft interpositions, two aortofemoral bypasses, one aortobifemoral bypass, three common femoral artery graft
interpositions, and two femoropopliteal bypasses. The popliteal artery (n  2), anterior tibial artery (n  2), and
subclavian artery (n  1) aneurysms were repaired primarily. There was no in-hospital mortality. One patient with an
abdominal aortic aneurysm had to undergo reoperation because of postoperative bleeding. The postoperative hospital
stay was 8.5  4.3 days. Two patients were lost to follow-up. During the follow-up period, two false aneurysms of the
common femoral artery were repaired with a graft interposition procedure. Another patient who had undergone an aortic
tube graft interposition was readmitted 9 months later with an external iliac artery aneurysm. The external iliac artery was
ligated through a retroperitoneal approach, and femorofemoral bypass was performed. In addition, one femoropopliteal
interposition graft was occluded, without disabling ischemia.
Conclusions: Although aneurysmal disease is rare in Behçet disease, it can complicate the clinical picture and cause
life-threatening complications. We believe that the establishment of remission before the surgical intervention decreases
the incidence of postoperative complications. Because recurrence at the site of anastomosis is possible, prolonged
monitoring is required. (J Vasc Surg 2005;42:673-7.)Behçet disease (BD) is a multisystemic disorder of
unknown etiology. The symptomatic triad, originally de-
scribed by Hulusi Behçet, includes oral aphthous ulcers,
genital ulcers, and ocular lesions. Although the disease is
common in the Mediterranean countries and Asia, it has a
worldwide distribution.1,2 The primary lesion in BD is a
type of systemic vasculitis that primarily affects the eyes,
skin, joints, blood vessels, and nervous system. The disease
is strongly associated with the presence of HLA-B51.3
Because no specific diagnostic test is available, the definitive
diagnosis is based on determination of several of its most
common clinical symptoms and signs.4
Vascular involvement is characterized by aneurysm for-
mation and occlusion of the large vessels.5,6 Although
arterial involvement is rare, it can complicate the clinical
picture and cause potentially fatal complications. The prog-
From the Departments of Cardiovascular Surgerya and Anesthesiology,b
Vakif Gureba Hospital, and GATA Military Training Hospital, Cardio-
vascular Surgery Service.c
Competition of interest: none.
Presented at the Fifty-third International Congress of the European Society
for Cardiovascular Surgery, Slovenia, 2004.
Reprint requests: Yusuf Kalko, MD, Department of Cardiovascular Surgery,
Vakif Gureba Hospital, Capa, 34390, Istanbul, Turkey (e-mail: ykalko@
mynet.com).
0741-5214/$30.00
Copyright © 2005 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.05.057nosis with arterial occlusions is better than that with aneu-
rysms, which are the major cause of death in patients with BD.
The surgical treatment of a Behçet aneurysm is chal-
lenging for the vascular surgeon because of the technical
difficulties and new postoperative false-aneurysm develop-
ment.1,7 Some authors recommended using the normal
arterial segments during the operation or preferred extra-
anatomic bypass procedures to avoid anastomotic compli-
cations.8 Aneurysmal lesions respond poorly to medical
treatment, and surgical intervention is mandatory. We be-
lieve that the cornerstone in the treatment of Behçet pa-
tients is the avoidance of surgical intervention during the
active stage of the disease. In this article, we report our
experience on 16 Behçet patients surgically treated at the
Department of Cardiovascular Surgery, Vakif Gureba Hos-
pital.
METHODS
This is a clinical research study consisting of 16 patients
who underwent a surgical intervention at our institution.
From October 2001 through May 2004, 16 patients from
Turkey underwent 18 surgical interventions because of arte-
rial aneurysms. The diagnosis of the disease was established by
using the clinical criteria defined by the International Study
Group for Behçet’s Disease clinical assessment (Table I).4,9Electrocardiogram and biochemical analysis was performed as
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dominal aortic and iliac aneurysms were established by com-
puted tomography (CT) or magnetic resonance imaging (Figs
1 and 2). All patients with an aneurysm were further examined
with Doppler ultrasonography or angiography to exclude any
concomitant extremity aneurysm. The patients with an accel-
erated erythrocyte sedimentation rate (15 mm/h), high C-re-
active protein (5 mg/L), and/or high white blood cell count
(10,000/L) were considered to be in active stage of the
disease, and, if not emergent, the surgical intervention was
deferred until remission. The patients who were at the active
stage of the disease received immunosuppressive therapy to
induce remission (glucocorticoids, 2 mg · kg1 · d1 for 15
days). At the end of 15 days, a high erythrocyte sedimentation
rate (15 mm/h) was considered as an indication for
immunosuppressant therapy, and cyclophosphamide (4
mg · kg1 · d1 orally for 10 days) was added to the treat-
ment. In patients who received cyclophosphamide, adequate
hydration was maintained to prevent adverse effects, and a
daily complete blood cell count and urine analysis were per-
formed to monitor its toxicity. In urgent cases, we did not wait
for remission, but a combination of cyclophosphamide and
glucocorticoids was administered during the postoperative
period.
After hospital discharge, all patients were followed up
regularly at 3-month intervals. The follow-up evaluation of
patients with abdominal aortic and iliac aneurysms was
performed with CT. The remaining patients were examined
with physical examination for patency of the graft and new
aneurysm formation, and, in case of suspicion, a further
examination with angiography was performed.
RESULTS
Eighteen arterial aneurysms in 16 patients were diag-
nosed during the study period. All patients were male. The
patients ranged in age from 24 to 52 years (mean, 37.4 
5.2 years). The mean duration of the disease was 7  3.4
years. A positive family history was present in 5 patients.
The other clinical manifestations are given in Table II.
There were six abdominal aortic, three common femo-
Table I. Diagnostic criteria of Behçet disease*
Major symptoms Minor symptoms
Recurrent genital ulcerations Gastrointestinal features
Aphthous ulceration or scarring Arthritis
Eye lesions Family history
Skin lesions Arthralgia
Positive pathergy test Cerebral nervous system
involvement




*Recurrent oral ulceration; minor aphthous, major aphthous, or herpeti-
form ulceration observed by physician or patient, recurring at least three
times in one 12-month period; and two of the symptoms in the table.ral, two iliac, two popliteal, two superficial femoral, and twoanterior tibial aneurysms (Fig 3) and one subclavian artery
aneurysm. All abdominal aortic aneurysms were infrarenal.
All patients but four were in remission at the time of
diagnosis. Those four patients with extremity aneurysms
received immunosuppressive therapy before the surgical
intervention to induce remission. There were five patients
with a ruptured abdominal aortic aneurysm. All patients
except one with a ruptured aneurysm were in remission at
the time of diagnosis. This one patient experienced hemo-
dynamic shock and underwent an emergent surgical inter-
vention. The aneurysm in the remaining patients was diag-
nosed on CT performed for the evaluation of abdominal
pain. The rupture in these patients was contained at the
posterior wall. All these patients underwent an aortic tube
graft interposition with an appropriately sized Dacron graft
(DuPont, Wilmington, Del).
During the study period, we performed two aortofem-
oral bypasses, one aortobifemoral bypass, three common
femoral artery graft interpositions, and two femoropopli-
teal bypasses. All these operations were performed by using
a polytetrafluoroethylene graft. We did not use autologous
material. The popliteal artery (n  2), anterior tibial artery
(n  2), and subclavian artery (n  1) aneurysms were
repaired primarily. During the operation, we performed
proximal and distal anastomoses in arteries free of disease
and in healthy tissue. The determination of the nondiseased
segment of the arterial tree is not always easy, but inspec-
tion and palpation may give some clues for diseased vessels.
The most important point during the reconstruction of the
anastomosis is the fragility of the arterial wall, and we
generally tried to reinforce the anastomotic site by using
Teflon felt pledgets (Meadox, Oakland, NJ). However, in
some cases, Teflon pledgets were not considered satisfactory
because of the high fragility of native vessel wall, and in
these cases, we did not hesitate to go more proximally to
find a stable segment. An arterial wall biopsy was performed
in all patients for histopathologic confirmation. None of
the patients developed intraoperative or postoperative
complications. One patient with a ruptured abdominal
aortic aneurysm had to undergo reoperation because of
postoperative bleeding. The postoperative hospital stay was
8.5  4.3 days for patients who underwent an abdominal
aortic operation and 6.5  4.3 days for patients who
underwent a peripheral arterial surgical intervention.
The pathologic examination of the specimens revealed
a loss of elastic fibers, destruction of internal elastic lamina,
and inflammatory cell infiltration. The other clinical mani-
festations of BD were present in 13 patients at the time of
operation. The diagnosis was established in the remaining 3
patients with arterial wall biopsy and clinical manifestations
detected during the postoperative follow-up period. Ery-
thema nodosum and joint disease were present in 77%
(10/13) and 61.5% (8/13) of patients, respectively. Two
patients had aneurysmal disease at multiple sites. The eval-
uation of patients who were referred with a diagnosis of
common femoral artery aneurysm revealed a concomitant
aortic aneurysm. Those patients underwent successful aor-
tic and common femoral artery tube graft interpositions.
age
ge of
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teal vein, n  1; greater saphenous vein, n  2).
All patients were followed up for a mean duration of
Fig 1. Computed tomographic im
Fig 2. Magnetic resonance ima17  4.2 months (range, 6-24 months). Two patients werelost to follow-up, and it is not certain that those two patients
were late survivors. There was no remote mortality. During
the follow-up period, two patients who were treated with an
of an abdominal aortic aneurysm.
an abdominal aortic aneurysm.aortofemoral bypass procedure developed new false aneu-
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repaired with a graft interposition procedure. Another patient
who had undergone an aortic tube graft interposition was
readmitted 9 months later with an external iliac artery aneu-
rysm. The external iliac artery was ligated through a retroper-
itoneal approach, and femorofemoral bypass was performed.
In addition, one femoropopliteal interposition graft was de-
tected to be occluded without disabling ischemia, and no
further surgical intervention was planned.
DISCUSSION
BD is a chronic inflammatory disease of unknown
origin. Although arterial involvement is rare, it can compli-
cate the clinical picture and cause potentially fatal compli-
Fig 3. Digital subtraction angiography image of a tibialis anterior
artery aneurysm.
Table II. The other clinical manifestations of the
patients
Manifestation n (%)
Deep venous thrombosis 4 (25%)
Erythema nodosum 10 (77%)
Joint disease 8 (61.5%)cations.The main histologic feature in BD is a type of vasculitis
that affects vessels of all sizes. The vascular involvement in
the disease is divided into three groups: venous occlusion,
arterial occlusion, and aneurysm formation. All of the pa-
tients usually have mucocutaneous lesions, including ery-
thema nodosum and necrotizing folliculitis.10 Superficial
thrombophlebitis is the most commonly seen disorder, and
it is frequently accompanied by skin lesions. Although some
authors have documented a strong association between
vascular involvement and ocular disease, we did not notice
a relationship in our population. The frequency of arterial
disease varies between 15% and 32% in patients with
BD.11,12 It is observed more commonly among men be-
tween the ages of 20 and 40 years. Although a positive
family history is common in patients with vascular involve-
ment, this was present in only five of our patients.
In BD, arterial aneurysm formation is more common
than occlusion. Behçet aneurysm, which has the tendency
to be multiple, can involve the entire arterial territory. The
most common location for the formation of the aneurysm is
the abdominal aorta.8 Pulmonary arterial aneurysms com-
monly seen in Behçet patients also tend to be multiple and
can be fatal because of the risk of perforation to the adjacent
bronchus. Unilateral subclavian arterial aneurysms have
been described in several studies.13,14 In our group, there
was one patient with a left subclavian artery aneurysm who
had been successfully treated.
Thrombotic venous lesions are well-known complica-
tions of BD and may be associated with fatal complications
such as pulmonary emboli. They usually involve the lower
extremity6 and can occur in almost any superficial or deep
vein. The management of venous thrombosis depends on
the location and severity of lesions. Anticoagulation along
with colchicine may be used for the treatment of venous
thrombosis. Although our sample did not include patients
without vascular involvement, the prevalence of deep venous
thrombosis in the series was 25%. The vascular manifestations
of the disease process may differ according to the geographic
distribution of patients. In a previous study performed in 137
Turkish patients, the reported incidence of venous and arterial
lesions was 24% and 3%, respectively.15 In contrast to the
Turkish experience, Japanese and European series reported
higher incidences of arterial lesions.16,17 However, we be-
lieve that the small sample size and the exclusion of patients
without vascular involvement are the limitations of our
study, and we need a larger sample size to draw a conclusion
about the exact incidence of venous lesions in Turkish
patients.
Early diagnosis of the aneurysm in BD is very important
because of the potentially fatal complications. The pathol-
ogy of Behçet aneurysms is different from that of athero-
sclerotic aneurysms. With the destruction of arterial wall
integrity, the vessel wall weakens, and this process may
predispose to false-aneurysm formation and rupture. The
clinical presentation may depend on the stage of the dis-
ease. During the active stage of the disease, all patients
should be screened for the presence of an arterial aneurysm.
However, the absence of this exacerbation does not elimi-
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and abdominal aneurysms may be diagnosed in the chronic
stage with various clinical symptoms and signs, including
abdominal pain or discomfort.
Treatment options in patients with arterial aneurysm
include endovascular stent implantation and surgical by-
pass. The main advantages of endovascular intervention are
lower mortality rates (0.6%-3.5%) and higher success
rates.18 However, the experience with endovascular treat-
ment in this specific subset of patients is usually limited, and
it is not possible today to compare the results of these two
modalities in Behçet patients. The surgical treatment of a
Behçet aneurysm is challenging for the vascular surgeon
because of the technical difficulties and new postoperative
false-aneurysm development. In addition, although this is
not always possible, avoiding surgical procedures during
the acute phase of the disease is preferred. Glucocorticoid
therapy is generally effective in controlling clinical manifes-
tations and disease progression in patients with active dis-
ease. Because there is a certainty of severe adverse effects
from sustained high-dose prednisone over long periods, we
aimed to shorten the duration by giving a higher dose at the
initial presentation. Fortunately, all patients responded well
to therapy, and we did not notice any adverse effects
associated with prednisone treatment.
One of the most important aspects of BD is aneurysmal
arteriopathy. The major problem of this complication is its
tendency to develop recurrent false aneurysms at anasto-
motic and traumatic sites, such as angiographic punctures.
Suturing of a prosthetic material to the diseased artery is
problematic with anastomotic complications. Although li-
gation of the affected artery may be tried, it is not always
possible because of the risk of possible ischemic complica-
tions. In such cases, some authors recommended using the
normal arterial segments during the operation or preferred
extra-anatomic bypass procedures to avoid anastomotic
complications. On the basis of our experience, we believe
that, in some cases without urgency, postponing the surgi-
cal intervention until remission may decrease the incidence
of anastomotic complications. Endovascular stent graft re-
pair of arterial aneurysms is reported to be a safe alternative
to the surgical intervention.
Doppler ultrasonography, CT, and magnetic resonance
imaging have shown promise in the diagnosis of aneurysmal
disease in Behçet patients. No specific laboratory markers
are associated with BD. The definitive diagnosis of the
disease may be very difficult, and in some patients, the acute
clinical presentation may not allow enough time for a
histopathologic confirmation. Five patients were associated
with the HLA-B5 antigen, and all these patients had a
positive family history. The postoperative follow-up of an-
eurysmal disease in Behçet patients should be comprehen-
sive, and all arteries must be extensively evaluated at regular
intervals. We believe that instead of conventional angiogra-
phy, noninvasive imaging modalities—including Doppler ul-
trasonography, CT, or magnetic resonance imaging angiog-
raphy—should be used in these patients to prevent
pseudoaneurysm formation during the follow-up period.Therefore, all patients were followed up regularly at 3-month
intervals, and for screening, we regularly performed Doppler
ultrasonography and CT angiography at 6-month intervals.
In conclusion, although arterial involvement is a rare
manifestation of the disease, it causes treatment challenges
because of the frequency of recurrences and life-threaten-
ing complications. Aneurysmal lesions respond poorly to
medical treatment, and surgery is mandatory. Because re-
currence at the site of anastomosis is possible, prolonged
monitoring is required. Immunosuppressive therapy
should be started in patients with arterial disease before the
surgical intervention and should be continued after surgery
to avoid postoperative early and late complications.
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